Where is Veltro Argento located?

Veltro Argento is headquartered in Stamford, US.

Veltro Argento

Venture capital

Stamford

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Fund manager profile

Veltro Argento is a venture fund manager based in Stamford. SEC filings show 1 venture fund on record, most recently Veltro Argento LP filed June 2020.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

Stamford, US

Founded

2020

Tracked investments

What they invest in

from 3 of 3 portfolio companies

Biotech ×3Healthtech ×1Medical Devices ×1

HQs:United States×3

Investments · 3 tracked

founders shown can be your intro path

By year:2021 · 1 2020 · 1 2018 · 13 dated

Adagio TherapeuticsNASDAQ: IVVDJul 2020SEC filingmedium confidence

BiotechWaltham, US

Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)Halley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)Ellie Hershberger(Executive Officer)

Board seatMarc Elia· per SEC Form D · $23.7M raise · filed Nov 2022

Co-investorsMithril Capital Management Polaris Partners

Fractylfractyl.com in 𝕏NASDAQ: GUTSJun 2021SEC filingmedium confidence

Fractyl develops therapies for obesity and type 2 diabetes, focusing on non-drug-based approaches rooted in understanding metabolic disease mechanisms.

BiotechHealthtechMedical DevicesLexington, US

HARITH RAJAGOPALAN(Executive Officer, Director)JAY CAPLAN(Executive Officer, Director)Harith Rajagopalan(Executive Officer, Director)inLISA DAVIDSON(Executive Officer)Ajay Royan(Director)Christopher Gabrieli(Director)

Board seatMarc Elia· per SEC Form D · $100M raise · filed Jun 2021

Co-investorsBessemer Venture Partners Catalio Capital Management, LP Emergent Medical Partners, LLP Mithril Capital Management Polaris Partners

SQZ Biotechnologiessqzbiotech.comMay 2018SEC filingmedium confidence

BiotechWatertown, US

Robert S. Langer, Sc.D.(Director)Armon Sharei, Ph.D.(Executive Officer, Director)Amy W. Schulman(Executive Officer, Director)Kris Elverum(Executive Officer)Howard Bernstein(Executive Officer)Klavs F. Jensen, Ph.D.(Director)

Board seatMarc Elia· per SEC Form D · $70.2M raise · filed Jun 2020

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.